PROTAC Market is driven by targeted protein degradation
Proteolysis Targeting Chimeras (PROTACs) represent a novel class of bifunctional molecules designed to harness the cell’s natural ubiquitin-proteasome system for selective degradation of disease-causing proteins. Each PROTAC comprises two ligands—one binding a target protein and the other engaging an E3 ubiquitin ligase—connected by a chemical linker. This innovative approach...
0 Comentários 0 Compartilhamentos 80 Visualizações 0 Anterior